Dartmouth researchers were awarded $9.6 million during February, including $4.3 million in new and competing awards. Among the recipients of recent new and competing grants, as reported by the Office of Sponsored Projects:
World Meteorological Organization
"Integrated Flood Management (IFM) for the Lake Victoria Basin"
National Space Biomedical Research Institute
"Improved Bubble Detection for EVA"
National Cancer Institute
"MYC Dependent Pathways in Apoptosis and Lymphomagenesis"
5-Year Award
International Business Machines, Inc.
"Asynchronous Buffered Computation Design and Engineering Framework Generator"
3-Year Award
Abbott Laboratories
"Phase I Study of ABT-751 w. Capecitabine"
Ligand Pharmaceutical
"Targretin and Tarceva for Aerodigestive Cancers"
Surdna Foundaton
"Public Impact Initiative"
Millennium Pharmaceuticals, Inc.
"Phase 2 Study of Velcade in Subjects W/Relapsed Mantle Cell Lymphoma"
and
Berlex Laboratories
"Phase II Comparing Combo Treatment with Fludarabine & Alemtuzuma to Fludarabine & Rituximab"
National Institutes of Health
"Purchase of a Multi-Parameter Flow Cytometer with High-Speed Sorting"
National Institute on Alcohol Abuse and Alcoholism
"Antipsychotics and Alcohol Drinking in Rodents"
2-Year Award
ORC Macro
"Assessment of Completeness of Reporting of Melanoma to Central Cancer Registries"
Holt, Rinehart, and Winston
"Chapter Reviews for Middle School Textbook"
National Endowment for the Arts
"04/05 Performances"
National Institute of Diabetes and Digestive and Kidney Diseases
"Insulin Regulation of the Adipocyte Glucose Transporter"
5-Year Award
State of Ohio, Department of Health
"Ohio Department of Health Services Contract"
National Science Foundation
"Molecular Genetic Analysis of Plant Circadian Rhythms"
4-year award
National Institute of Allergy and Infectious Diseases
"Cognate Activation of B Lymphocytes"
5-Year Award
National Institute of General Medical Sciences
"Regulation of Lin-4 Expression in Caenorhabditis Elegans"
2-Year Award
NS Pharma, Incorporated
"Dose Escalation Study of IV Administered NS-9 in Subjects with Liver Metastases"
National Science Foundation
"CAREER: Chittagong Hill Tracts Linguistic Documentation"
5-Year Award
American Society for Clinical Oncology
"Mechanisms for an Active Targeted Combination Therapy"
National Cancer Institute
"Reconstitution of a Hedgehog Signaling Complex"
5-Year Award
American Heart Association
"A Novel Mouse Model of Myxomatous Valvular Disease"
National Foundation for Cancer Research
"Prevention of Cancer with Anti-Inflammatory Agents"
2-Year Award
National Institute of Diabetes and Digestive and Kidney Diseases
"The Role of the Type 3 Deiodinase in Development"
4-Year Award
National Aeronautics and Space Administration
"Electrodynamics of Magnetosphere-Ionosphere Coupling at High Latitudes Including Plasma Transport"
National Institute of Neurological Disorders and Stroke
"Mechanism of Prion Propagation"
4-Year Award
National Institute of Mental Health
"The Own-Race Bias and the Cerebral Hemispheres"
2-Year Award
National Cancer Institute
"Immune Surveillance in Murine Gammaherpesvirus Infection"
5-year Award
Award commitment from the sponsoring agency is for a single year unless otherwise indicated.
